Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001230084 | SCV001402553 | uncertain significance | Hereditary diffuse gastric adenocarcinoma | 2022-11-30 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Studies have shown that disruption of this splice site results in the activation of a cryptic splice site in intron 3 and exon 2 (Poster G20 in http://jmd.amjpathol.org/article/S1525-1578(16)30178-7/pdf). RNA analysis provides insufficient evidence to determine the effect of this variant on CDH1 splicing (Invitae). ClinVar contains an entry for this variant (Variation ID: 957154). This variant has not been reported in the literature in individuals affected with CDH1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 3 of the CDH1 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in the loss of 53 or insertion of 19 amino acid residue(s), but is expected to preserve the integrity of the reading-frame. |
Baylor Genetics | RCV004570571 | SCV005060095 | uncertain significance | Familial cancer of breast | 2024-01-21 | criteria provided, single submitter | clinical testing |